Confido Health raises $12.5 million led by Z47 to automate clinic paperwork with AI

Confido Health, a start-up that uses artificial intelligence to handle administrative work for healthcare providers, announced on Wednesday, October 14, 2026, that it has raised $12.5 million in a Series A extension led by Z47, the venture firm formerly known as Matrix Partners India. The extension takes its total Series A funding to $22.5 million, building on a $10 million round led by Blume Ventures in 2025. Existing investors Together Fund and Blume Ventures also took part, and healthcare investor Justin Saks has joined as an investor and board adviser. The company, founded in 2022 by Chetan Reddy and Vichar Shroff, says it will use the money to expand CareOS, its platform for automating tasks across the software that clinics already use.

Healthcare runs on paperwork. Clinics spend large amounts of staff time answering calls, scheduling appointments, checking insurance, updating records and chasing bills. In the United States, where Confido's customers are, these administrative costs are high and many practices struggle to hire enough front-office staff. Tools that take over routine tasks can free up nurses and staff for patients and help smaller practices stay afloat.

Confido began with AI-powered patient calls and is now expanding into a wider layer that works across a clinic's existing software. That approach matters because most healthcare providers cannot easily replace their record-keeping and billing systems. A tool that plugs into more than 50 of them, rather than asking a clinic to switch, has a better chance of being adopted. The company describes this as moving clinics from simply storing data to acting on it.

The round also reflects a wider trend in which India-focused venture firms such as Z47 and Blume Ventures are funding AI companies that sell into the US market. Healthcare administration is one of the areas where AI agents, software that can carry out multi-step tasks, are being used in real operations rather than demonstrations. Investors are betting that companies with working products and paying customers will win as the market matures.

Confido's performance numbers, such as the 95% handling rate and staff capacity gains, are the company's own figures and have not been independently verified. Patient data privacy and accuracy will also be closely watched as AI takes on more tasks inside medical offices.

Short-term: The new money will go into expanding CareOS beyond calls into connected administrative workflows, and likely into hiring and sales to reach more practices.

Long-term: If AI agents prove reliable in healthcare offices, they could change how clinics staff their front desks and reduce administrative costs. They will also face growing scrutiny over data privacy, errors and accountability.

Who is affected: Clinics and medical practices, front-office healthcare workers, patients who deal with appointment and billing systems, and investors in AI and health-technology start-ups.

Questions and Answers